Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5309 participants
OBSERVATIONAL
2012-06-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antidepressant Incomplete Response Depression
NCT00782964
Major Depressive Disorder (MDD)
NCT01662817
Primary Prevention of Major Depression Based on the Level and Profile of Risk of Primary Care Attenders: Cluster, Controlled, Randomised Trial
NCT01151982
Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
NCT05537558
Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)
NCT00770289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jorge Cervilla, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital San Cecilio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIS-NES-XXX-2011-3 Clinical Study Report Synopsis
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PismaEP
Identifier Type: -
Identifier Source: secondary_id
NIS-NES-XXX-2011/3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.